Cooper PE Ratio 2006-2018 | COO

Current and historical p/e ratio for Cooper (COO) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cooper PE ratio as of December 18, 2018 is 21.22.
Cooper PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-12-18 247.22 325.29
2018-10-31 258.31 $0.76 339.88
2018-07-31 260.50 $2.54 102.56
2018-04-30 228.68 $2.60 87.95
2018-01-31 244.64 $3.49 70.10
2017-10-31 240.20 $7.52 31.94
2017-07-31 243.81 $6.97 34.98
2017-04-30 200.26 $6.67 30.02
2017-01-31 184.54 $6.07 30.40
2016-10-31 175.95 $5.59 31.48
2016-07-31 182.37 $5.11 35.69
2016-04-30 152.97 $4.23 36.16
2016-01-31 131.06 $3.94 33.26
2015-10-31 152.22 $4.14 36.77
2015-07-31 176.83 $4.02 43.99
2015-04-30 177.87 $4.91 36.23
2015-01-31 157.47 $5.30 29.71
2014-10-31 163.69 $5.52 29.65
2014-07-31 160.67 $6.04 26.60
2014-04-30 131.71 $6.03 21.84
2014-01-31 124.10 $5.93 20.93
2013-10-31 128.99 $5.96 21.64
2013-07-31 127.13 $6.27 20.28
2013-04-30 110.18 $5.84 18.87
2013-01-31 101.15 $5.44 18.59
2012-10-31 95.76 $5.06 18.93
2012-07-31 75.09 $4.75 15.81
2012-04-30 87.94 $4.17 21.09
2012-01-31 71.95 $3.78 19.03
2011-10-31 69.09 $3.62 19.08
2011-07-31 76.25 $3.50 21.79
2011-04-30 74.64 $3.58 20.85
2011-01-31 57.14 $2.95 19.37
2010-10-31 49.14 $2.43 20.22
2010-07-31 38.71 $2.06 18.79
2010-04-30 38.71 $1.68 23.04
2010-01-31 35.15 $2.12 16.58
2009-10-31 27.86 $2.21 12.60
2009-07-31 27.29 $2.20 12.40
2009-04-30 28.56 $2.11 13.53
2009-01-31 18.84 $1.82 10.35
2008-10-31 16.35 $1.44 11.35
2008-07-31 33.42 $0.28 119.37
2008-04-30 34.69 $0.06 578.10
2008-01-31 39.03 $-0.20 0.00
2007-10-31 41.59 $-0.23 0.00
2007-07-31 49.64 $0.58 85.59
2007-04-30 50.58 $0.85 59.50
2007-01-31 47.21 $1.15 41.05
2006-10-31 57.00 $1.42 40.14
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.013B $2.533B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $60.586B 20.59
McKesson (MCK) United States $21.863B 8.35
Align Technology (ALGN) United States $16.554B 42.24
AmerisourceBergen (ABC) United States $16.319B 11.88
Cardinal Health (CAH) United States $14.280B 9.59
Laboratory Of America Holdings (LH) United States $13.500B 12.22
Henry Schein (HSIC) United States $12.155B 19.99
DENTSPLY SIRONA (XRAY) United States $8.272B 16.52
West Pharmaceutical Services (WST) United States $7.558B 37.51
Merit Medical Systems (MMSI) United States $2.990B 35.41
Patterson (PDCO) United States $2.066B 15.77
CONMED (CNMD) United States $1.740B 28.91
STAAR Surgical (STAA) United States $1.479B 152.32
Atrion (ATRI) United States $1.404B 40.14
Antares Pharma (ATRS) United States $0.454B 0.00
Lifevantage (LFVN) United States $0.190B 26.92
Invacare (IVC) United States $0.144B 0.00
Endologix (ELGX) United States $0.067B 0.00
Pro-Dex (PDEX) United States $0.053B 23.81
Aceto (ACET) United States $0.038B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Biolase (BIOL) United States $0.019B 0.00
Milestone Scientific (MLSS) United States $0.012B 0.00